Ledger.Open graph →
SEC Form D · filed October 24, 2013

Sideris Pharmaceuticals, Inc

Offering
$32.0M
Sold
$17.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (5)

Steven M. Krausz · Menlo Park, CADirectorKazumi Shiosaki · Boston, MAExec · DirectorRobert A. Van Doorn · Vancouver, British Columbia, CanadaDirectorCraig N. Tennier · Grand Cayman, Cayman IslandsExec · DirectorDouglas Reed · Chapel Hill, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗